In NASH, pro-inflammatory B2 cell accumulation in liver has been demonstrated to result in increased expression of pro-inflammatory cytokines, such as TNF-α and IL-6 through TLR4/MyD88 signaling pathway, that ultimately exacerbating liver inflammation and fibrosis. Here, MYD88 is linked to metabolic dysfunction-associated steatohepatitis.